Absci to Participate in the 26th Annual Needham Growth Conference
January 03 2024 - 8:00AM
Absci Corporation (Nasdaq: ABSI), a generative AI drug creation
company, today announced the company will be participating
virtually in the upcoming 26th Annual Needham Growth Conference.
Absci management is scheduled to present on
Friday, January 19th at 9:30 a.m. Eastern Time (6:30 a.m. Pacific
Time). Interested parties may access a live and archived webcast of
the presentation on the company’s investor relations website at:
investors.absci.com.
About Absci
Absci is a generative AI drug creation company
that combines AI with scalable wet lab technologies to create
better biologics for patients, faster. Our Integrated Drug
Creation™ platform unlocks the potential to accelerate time to
clinic and increase the probability of success by simultaneously
optimizing multiple drug characteristics important to both
development and therapeutic benefit. With the data to train, the AI
to create, and the wet lab to validate, we can screen billions of
cells per week, allowing us to go from AI-designed antibodies to
wet lab-validated candidates in as little as six weeks. Our vision
is to deliver breakthrough therapeutics at the click of a button,
for everyone. Absci’s headquarters is in Vancouver, WA, with our AI
Research Lab in New York City and an Innovation Center in Zug,
Switzerland. Visit www.absci.com and follow us on LinkedIn
(@absci), X (Twitter) (@Abscibio), and YouTube.
Availability of Other Information about
AbsciInvestors and others should note that we routinely
communicate with investors and the public using our website
(www.absci.com) and our investor relations website
(investors.absci.com), including without limitation, through the
posting of investor presentations, SEC filings, press releases,
public conference calls and webcasts on these websites, as well as
on X (Twitter), LinkedIn and YouTube. The information that we post
on these websites and social media outlets could be deemed to be
material information. As a result, investors, the media, and others
interested in Absci are encouraged to review this information on a
regular basis. The contents of our website and social media
postings, or any other website that may be accessed from our
website or social media postings, shall not be deemed incorporated
by reference in any filing under the Securities Act of 1933, as
amended.
Investor ContactAlex KhanVP,
Finance & Investor Relationsinvestors@absci.com
Media
Contactpress@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Jul 2024 to Aug 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Aug 2023 to Aug 2024